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A Dicer-2-Dependent 80S Complex Cleaves
Targeted mRNAs during RNAi in Drosophila
R2D2, apparently acts as an intermediary, linking the
initiation and effector phases of RNAi (Liu et al., 2003).
Despite our expanding knowledge of RNAi, the RISC
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Molecular Biology and Cell Biology assembly pathway and the full composition of the silenc-
ing complex remain unknown.Northwestern University
2205 Tech Drive In their attempts to resolve these outstanding ques-
tions, several groups have identified active RISCs ofEvanston, Illinois 60208
varying sizes. Hammond et al. (2001) isolated a 500
kDa complex from Drosophila S2 cell extracts and, using
extracts prepared from Drosophila embryos, Nyka¨nenSummary
et al. (2001) identified a smaller232 kDa silencing com-
plex. Interestingly, a still smaller (160 kDa) silencingWe use native gel electrophoresis to characterize
complexes that mediate RNA interference (RNAi) in complex was isolated from HeLa cell extracts (Martinez
et al., 2002). All three complexes can cleave targetedDrosophila. Our data reveal three distinct complexes
(R1, R2, and R3) that assemble on short interfering mRNAs, but it is unclear how they are related to one
another. Furthermore, we do not know whether theseRNAs (siRNAs) in vitro. To form, all three complexes
require Dicer-2 (Dcr-2), which directly contacts siRNAs complexes represent the full array of RISC-associated
factors or if they represent core species that retainin the ATP-independent R1 complex. R1 serves as a
precursor to both the R2 and R3 complexes. R3 is RNAi activity. To complicate matters further, the 550
kDa microRNA (miRNA) complex known as the miRNPa large (80S), ATP-enhanced complex that contains
unwound siRNAs, cofractionates with known RNAi (Mourelatos et al., 2002) shows striking similarities to
RISC. When endogenous miRNAs are presented with afactors, and binds and cleaves targeted mRNAs in a
cognate-siRNA-dependent manner. Our results estab- perfectly complementary target, they can act as cleav-
age determinants for miRNP-mediated target destruc-lish an ordered biochemical pathway for RISC assem-
bly and indicate that siRNAs must first interact with tion, like their siRNA cousins in RISC (Hutvagner and
Zamore, 2002). Conversely, when siRNA-programmedDcr-2 to reach the R3 “holo-RISC” complex. Dcr-2 does
not simply transfer siRNAs to a distinct effector com- RISCs are presented with transcripts containing imper-
fect binding sites, they can act as translational repres-plex, but rather assembles into RISC along with the
siRNAs, indicating that its role extends beyond the sors, like their miRNA cousins in the miRNP (Doench et
al., 2003; Zeng et al., 2003). Clearly there is significantinitiation phase of RNAi.
overlap between the two silencing pathways, and the
corresponding complexes are apparently flexible in theirIntroduction
function. But what, if anything, distinguishes one com-
plex from the other remains a mystery.In response to invasive double-stranded RNAs (dsRNAs),
like those produced by viruses and transposons, the cells In this study, we use native gel electrophoresis to
elucidate the pathway that assembles RISC and relatedof many organisms mount a defense now known as RNA
interference (RNAi) (for review, see Denli and Hannon, siRNA-associated ribonucleoproteins (siRNPs). We iden-
tify a Dcr-2/siRNA initiator complex that cannot cleave2003). In the first phase of this defense, the enzyme
Dicer cleaves the dsRNAs into short interfering RNAs targeted mRNAs. The initiator complex serves as a direct
precursor to a “holo-RISC” that is much larger than(siRNAs), roughly 21 to 25 nucleotides in length (Hamil-
ton and Baulcombe, 1999; Zamore et al., 2000; Bernstein those previously described and has all of the character-
istics of an active RNAi effector. It harbors known RISCet al., 2001). To act, the nascent siRNAs must be incorpo-
rated into the RNA-induced silencing complex (RISC) components and, surprisingly, also contains two com-
ponents of the dsRNA processing machinery, Dcr-2(Hammond et al., 2000) where they are unwound and acti-
vated in an ATP-dependent manner (Nyka¨nen et al., and R2D2.
2001). Only then, as single-stranded species, are they
competent to bind complementary mRNAs for RISC- Results
mediated destruction (Martinez et al., 2002).
Key aspects of RNAi have been elucidated and impor- Identification of Silencing Complexes
tant proteins continue to emerge. In Drosophila, proteins To examine RISC and related silencing complexes, we
like VIG, dFXR, TSN, and Ago2 have been identified as used native gel electrophoresis to assay complex forma-
RISC-associated components (Hammond et al., 2001; tion. When we incubated radiolabeled siRNAs in Drosoph-
Caudy et al., 2002, 2003; Ishizuka et al., 2002), although ila embryo extract and analyzed the mixture by native gel
the precise roles they play remain unclear. Additionally, electrophoresis, three distinct complexes appeared that
Dcr-2 (one of two Dicer isoforms in Drosophila) has been we called R1, R2, and R3 (Figure 1). Additionally, some
implicated in dsRNA processing, but is not known to of the labeled siRNAs appeared at the top of the lane,
act later in the RNAi pathway. Its associated factor, as commonly observed when large nucleoprotein com-
plexes are analyzed by native gel (e.g., Konarska and
Sharp, 1986; Shaw et al., 1989; Nadano et al., 2001); we*Correspondence: erik@northwestern.edu
Cell
84
bryo extracts, Nyka¨nen et al. (2001) observed two siRNA
binding complexes. The smaller of these two complexes
(232 kDa) coeluted with mRNA cleavage activity
whereas the larger one (360 kDa) did not. They also
detected significant mRNA cleavage activity along with
unwound siRNAs in the void fractions, presumably from
complexes too large to enter the gel matrix. To examine
how the native gel complexes compare with the previously
identified siRNA binding complexes, we performed a simi-
lar fractionation. Extracts treated with radiolabeled Pp-
luc siRNAs were chromatographed on a Superdex-200
column. Fractions were collected and assayed both for
their ability to form complexes on a native gel and to
cleave targeted Pp-luc mRNAs. Of the three complexes,
only R1 eluted as a discrete peak, migrating between the
440 kDa and 232 kDa size markers (Figure 2A, fractions
18–30). We did not detect the R2 complex. However,
we did observe R3, which eluted in the void (Figure 2A,
fractions 4 and 6). When we assayed the fractions for
mRNA cleavage activity, most of it was also in the void
(Figure 2B). We observed neither discrete complexes
nor significant cleavage activity in the 232 kDa frac-
tions as previously observed, perhaps due to the milder
conditions (lower flow rate and temperature) used during
our fractionation. Based on these results, we conclude
that R1 corresponds to the360 kDa complex identified
by Nyka¨nen et al. (2001).
To determine whether any of the native gel complexes
exist as pre-formed apo-complexes in the absence of
siRNAs, we fractionated a naı¨ve extract (i.e., one which
Figure 1. Drosophila siRNP Complexes Can Be Resolved by Native had not been preincubated with exogenous siRNA du-
Gel Electrophoresis
plexes) using the same gel filtration procedure (Figure
Radiolabeled siRNAs were incubated with lysate from wild-type
2C). The fractions were monitored for complex formationDrosophila embryos (lanes 3–6) or dcr-2 null mutant embryos (lanes
by incubation with radiolabeled siRNA duplexes, fol-1–2), treated with heparin, and analyzed by native gel electrophore-
lowed by native gel analysis. Only R1 formed, indicatingsis. The siRNA 5 termini are given at the top of each lane. The
samples shown in lanes 1, 2, 5, and 6 contained ATP and an ATP- that its siRNA binding activity remains intact in the ab-
regenerating system, whereas the samples shown in lanes 3 and 4 sence of siRNA duplexes (Figure 2C, fractions 18–32).
were depleted of ATP with hexokinase and glucose. The origin of In contrast, we did not observe the R3 complex, indicat-
electrophoresis is shown on the left; siRNAs present at the top of
ing that R3 is formed by factors that are separated orthe lane are denoted by an asterisk on the right. R1, R2, and R3
lost during chromatography.siRNP complexes and unbound siRNA are indicated on the right.
R1 Is an RNAi Initiator Complex that Contains Dcr-2
Since the factors required to form R1 remained intactdiscuss the nature of this material below. The R1, R2,
and R3 complexes only form on phosphorylated siRNAs after gel filtration, we combined the R1-forming gel filtra-
tion fractions (Figure 2C, fractions 18–32) and furtheror those that can become phosphorylated by incubation
with ATP; they do not form on 5-hydroxyl-bearing purified them by MonoQ ion exchange chromatography.
The MonoQ fractions were incubated with radiolabeledsiRNAs incubated in extracts depleted of ATP (Figure
1, lane 3), as expected for bona fide RNA silencing com- siRNAs to monitor R1 formation, yielding a discrete R1
peak (Figure 3A). Since R1 formation requires Dcr-2, weplexes (Nyka¨nen et al., 2001). All three complexes as-
semble on different, unrelated siRNAs (data not shown). reasoned that it may contain Dcr-2 and perform func-
tions attributed to Dcr-2, such as dsRNA processing.Notably, R3 formation exhibits the ATP enhancement
expected of an RNAi effector complex (Figure 1). To Indeed, when the MonoQ fractions were treated with
labeled dsRNAs, only those that could form R1 (Figureaddress the relevance of the native gel complexes to
RNAi, we examined their formation in an extract pre- 3A) were active for dsRNA processing (Figure 3B).
Extracts that lack Dcr-2 are deficient in target mRNApared from dcr-2 null mutant embryos. This mutant is
RNAi defective both in vivo and in vitro (Lee et al., 2004 cleavage, even when pre-cleaved siRNAs are used as
the silencing trigger (Lee et al., 2004). To determine[this issue of Cell]). Significantly, the native gel com-
plexes do not form in a lysate prepared from the mutant whether the R1 complex might be required for the ef-
fector phase of RNAi, we tested whether the R1-formingembryos (Figure 1, lanes 1 and 2). Taken together, the
salient features of these complexes and the require- MonoQ fractions (Figure 3A) could rescue the mRNA
cleavage defect in a dcr-2 mutant extract. Neither thements for their formation correlate precisely with known
prerequisites for RNAi. MonoQ fractions nor the dcr-2 extract, alone, could di-
rect mRNA cleavage (Figure 3C, lanes 5–12 and laneUsing gel filtration chromatography on Drosophila em-
siRNP Assembly in the RNAi Pathway
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Figure 2. Target mRNA Cleavage Activity
Correlates with R3 but Not R1
(A) Wild-type Drosophila embryo lysate was
incubated with radiolabeled Pp-luc siRNA
and then fractionated in a Superdex-200 gel
filtration column. Even-numbered fractions
were analyzed by native gel electrophoresis.
“Lysate” denotes the unfractionated mixture.
The elution profile of molecular weight stan-
dards is given at the bottom (V0, void volume;
669 kDa, thyroglobulin; 440 kDa, ferritin; 232
kDa, catalase). Complexes and unbound siRNA
are indicated on the right.
(B) Aliquots of the fractions used in (A) were
tested for Pp-luc mRNA cleavage activity;
RNAs from each reaction were then sepa-
rated in a 6% denaturing polyacrylamide gel.
Control samples include unreacted Pp-luc
mRNA target (“Input”), reaction with lysis
buffer in place of lysate (“No lysate”), reaction
with unfractionated lysate in the absence of
siRNA (“No siRNA”), and reaction with unfrac-
tionated lysate in the presence of Pp-luc
siRNA (“Complete”). The mobilities of 5 end-
labeled uncleaved Pp-luc mRNA target and
cleaved product are shown on the right.
(C) As in (A), except that chromatography was
performed on extract in the absence of siRNA.
Radiolabeled Pp-luc siRNA was then added
to each fraction and complexes were visual-
ized by native gel electrophoresis.
13), even when triggered by a synthetic 21 nt siRNA siRNA duplexes with an R1-forming MonoQ fraction
(Figure 3A, fraction 5). We then added excess, unlabeledduplex that does not require Dcr-2-mediated dsRNA
processing. However, when the MonoQ fractions and siRNA duplexes followed by whole, wild-type extract.
Aliquots were removed at specific time points and loadeddcr-2 extract were combined, mRNA cleavage activity
was reconstituted (Figure 3C, lanes 16 and 17). The data onto a running, native gel. As shown in Figure 3E, R1
quickly gives rise to R2 (lane 1), and later to R3 (lane 7).suggest that later events in the RNAi pathway, including
mRNA cleavage, are at least indirectly dependent upon Between 30 and 60 min, R2 disappears and R3 arises
(Figure 3E, lanes 6 and 7), suggesting that R2 may con-the R1 complex.
We next performed a timecourse experiment to see vert to R3 during this interval; however, these results
do not exclude the possibility that R3 might form directlyhow quickly the complexes form relative to one another
(Figure 3D). R1 forms rapidly, reaching a maximum after from R1, with R2 representing an unstable off-pathway
complex. Both R2 and R3 were derived from R1 becauseabout five minutes. R2 forms almost as quickly, but
R3 lags significantly behind. This experiment, combined when preformed R1 was simultaneously treated with
both labeled and unlabeled siRNAs and then incubatedwith our previous data, suggests that the complexes
might be linked within a common pathway. In parallel with whole extract, no complexes formed (Figure 3E,
lane 9), demonstrating that the amount of unlabeledtimecourses, R3 complex assembly precedes target
mRNA cleavage, as expected of an active effector com- siRNA added was sufficient to block de novo complex
formation on labeled siRNA duplexes. As a negativeplex (Supplemental Figure S1 at http://www.cell.com/
cgi/content/full/117/1/83/DC1). control, we performed the chase with buffer rather than
extract and observed no higher order complex formationTo address the potential precursor-product relation-
ship between R1 and the other complexes, we per- (Figure 3E, lane 8), demonstrating that R1 has no intrinsic
ability to convert to R2 or R3. The delayed kinetics offormed a pulse-chase experiment that was monitored
by native gel electrophoresis (Figure 3E). To do this, we R3 formation in this experiment (relative to the standard
timecourse in Figure 3D) is possibly due to the presenceformed R1 by incubating trace amounts of radiolabeled
Cell
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Figure 3. Partially Purified R1 Complex Is a Precursor in a RISC Assembly Pathway
(A) Fractions 18–32 from the gel filtration column used in Figure 2C were pooled and further purified by ion exchange chromatography in a
MonoQ column. Aliquots from desalted fractions 3–12 were assayed for their ability to form R1 complex on radiolabeled Pp-luc siRNA. Lane
1 shows complex formation with unfractionated lysate. Complexes and unbound siRNA are indicated on the right.
(B) MonoQ fractions were incubated with radiolabeled Pp-luc dsRNA in the presence of ATP. RNAs from each reaction were then separated
in a denaturing 15% polyacrylamide gel. Control samples include a 22 nt radiolabeled RNA marker (“Marker”), unreacted dsRNA (“Input”),
reaction with lysis buffer in place of lysate (“No lysate”), and reaction with unfractionated lysate (“Crude lysate”). The mobilities of unreacted
Pp-luc dsRNA and product siRNA are given on the right.
(C) MonoQ fractions 3–10 were incubated with unlabeled Pp-luc siRNA and radiolabeled Pp-luc mRNA target, with (lanes 14–21) or without
(lanes 5–12) lysate from dcr-2 mutant embryos. RNAs from each reaction were then separated in a denaturing 6% polyacrylamide gel. Control
siRNP Assembly in the RNAi Pathway
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Figure 4. Dcr-2 Interacts with siRNAs in the R1 Complex
(A) Radiolabeled, 5-phosphorylated Pp-luc siRNA duplex was incubated with wild-type extract (lane 1) or dcr-2 mutant extract (lane 2) and
irradiated with 254 nm light. Samples were denatured in SDS sample buffer and loaded onto a 6% polyacrylamide SDS gel, and crosslinked
proteins were detected by autoradiography. For immunoprecipitation experiments (“IP,” lanes 4–7), extracts were treated as in lane 1, but
were additionally incubated with protein A sepharose beads conjugated to antibodies or to preimmune serum (as indicated at the top of each
lane). The “Nonspecific” antibody was directed against protein kinase C. “Total” sample was as in lane 1. The mobilities of Dcr-1 and Dcr-2
crosslinked bands are indicated on the right.
(B) Two siRNP assembly/UV crosslinking reactions as in lane 5 of (D) were loaded onto two separate lanes of a 4% polyacrylamide native
gel. One lane was dried and subjected to autoradiography (top); the other was embedded within the stacking portion of an 8% polyacrylamide
SDS gel and subjected to 2nd-dimension electrophoresis (bottom). For the native gel, complexes and unbound siRNAs are indicated at the
top. For the denaturing gel, the mobilities of the Dcr-1 and Dcr-2 crosslinked bands are given on the left.
(C) Crosslinking reactions were performed with siRNAs bearing 5-phosphate or 5-hydroxyl termini, in the presence or absence of heparin
and ATP (as indicated at the top of each lane). Products were analyzed by electrophoresis in an 8% polyacrylamide-SDS gel.
(D) Radiolabeled Pp-luc siRNAs were incubated in wild-type extract, treated with heparin, and loaded onto a native gel. The siRNA 5 termini
are given at the top of each lane; reactions in lanes 2, 4, 6, and 8 were ATP depleted. In lanes 5–8, incubated samples were placed on ice
and irradiated with 254 nm light before heparin addition; control samples in lanes 1–4 were held on ice without UV irradiation before heparin
addition. Complexes and unbound siRNA are indicated on the right.
of a large excess of unlabeled competitor siRNAs. Taken the wild-type lysate, a number of proteins crosslinked
to the siRNAs, including a200 kDa protein roughly thetogether, these results indicate that the R1 complex is
a precursor to the R2 and R3 complexes in an ordered size of Dcr-2 and a 250 kDa protein the size of Dcr-1
(Figure 4A, lane 1). In the dcr-2 lysate, the 200 kDaassembly pathway.
protein was undetectable, suggesting that it is, in fact,
Dcr-2 (Figure 4A, lane 2). In support of this result, anti-Dcr-2 Interacts with siRNAs in the Native
Gel Complexes bodies directed against R2D2, a known Dcr-2-associated
protein (Liu et al., 2003), specifically coimmunoprecipi-To see if Dcr-2 is closely associated with siRNAs within
the R1 complex, we performed UV crosslinking experi- tated the200 kDa band (Figure 4A, lane 6). To confirm
the identity of the presumptive Dcr-1 band, we per-ments. We first characterized protein/siRNA crosslinks
by incubating radiolabeled siRNA duplexes in both wild- formed an immunoprecipitation experiment with anti-
bodies directed against Dcr-1 (Bernstein et al., 2001).type and dcr-2 mutant lysates. The reactions were then
irradiated with UV light and analyzed by SDS-PAGE. In These antibodies specifically immunoprecipitated the
reactions (lanes 1–4) were as in Figure 2B; an additional control reaction was performed with dcr-2 mutant lysate alone (lane 13). The mobilities
of 5 end-labeled uncleaved Pp-luc mRNA target and cleaved product are shown on the right.
(D) Following addition of radiolabeled siRNA to wild-type Drosophila embryo lysate, aliquots were removed at various times (shown at the
top of each lane), treated with heparin, and loaded onto a running native gel. Lane 1 contained the input siRNA in the absence of lysate and
was loaded at the same time as lane 8. Complexes and unbound siRNA are indicated on the right. Unbound siRNAs ran off the bottom of
the gel in lanes 2–5.
(E) Left: scheme for the chase experiment to determine whether the R1 complex serves as a precursor to the R2 and R3 complexes. Right:
radiolabeled Pp-luc siRNA was incubated with fraction 5 from the MonoQ column to form R1 complex, mixed with excess unlabeled competitor
Pp-luc siRNA, and then chased with unfractionated extract as depicted to the left. Aliquots were removed at various times after extract
addition (given at the top of each lane), treated with heparin, and loaded onto a running native gel (lanes 1–7). A control experiment (lane 8)
used lysis buffer rather than total extract during the chase. In the additional control experiment shown in lane 9, the excess unlabeled siRNA
duplex was added at the outset (along with the radiolabeled siRNA duplex). Complexes and unbound siRNA are indicated.
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250 kDa band from UV-treated extracts, indicating that cate that Dcr-2 can interact transiently with 5-hydroxyl
siRNAs within R1. This interaction can be trapped bysiRNAs can crosslink to Dcr-1 (Figure 4A, lane 4); other
bands present in the Dcr-1 immunoprecipitates also ap- UV crosslinking but is otherwise unsustainable in the
absence of a 5-phosphate. Since both functionalpeared in the negative control samples, indicating that
they were nonspecific. (5-phosphate) and nonfunctional (5-hydroxyl) siRNAs
are able to interact with Dcr-2 within the R1 initiatorWe next examined whether Dcr-2 and siRNAs closely
interact within the R1 complex by performing a two- complex, the rejection of 5-hydroxyl siRNAs occurs at
some point in the RNAi pathway after initial binding todimensional gel electrophoresis experiment on UV-irra-
diated extracts. To do this, wild-type embryo extracts Dcr-2.
were incubated with radiolabeled siRNAs, subjected to
UV irradiation, treated with heparin, and analyzed by R3 Is an RNAi Effector Complex
native gel electrophoresis. The entire native gel lane was As noted previously, both mRNA cleavage activity and
then excised, layered horizontally on an SDS-polyacryl- the R3 complex fractionate in the void by Superdex-
amide gel, and subjected to electrophoresis in the sec- 200 chromatography (Figures 2A and 2B), hinting at a
ond dimension. When visualized in the second dimen- possible role for R3 in target cleavage. However, we
sion, R1 resolves into several bands, one of which is were unable to correlate the R3 complex with mRNA
Dcr-2 (Figure 4B). Interestingly, the Dcr-2 crosslink trails cleavage activity because both elute in the void volume
into the R2 and R3 regions of the gel. Based on these and not as distinct peaks. To isolate the R3 complex
data, we conclude that R1 harbors Dcr-2 in intimate and to determine whether it can cleave targeted mRNAs,
association with siRNAs. This association persists in we incubated radiolabeled Pp-luc siRNA duplexes with
higher order siRNPs, on a pathway leading from the R1 extract and fractionated the mixture through a Super-
complex to R3. dex-200 column. The void volume was collected and
In addition to Dcr-2, we observed a crosslinked spe- centrifuged through a 20%–50% sucrose gradient to
cies in R1 and higher order siRNPs corresponding to separate high molecular weight complexes. Fractions
Dcr-1 (Figure 4B). Since R1 formation absolutely requires were then tested both for the presence of the R3 com-
Dcr-2 (Figure 1), this result suggests that Dcr-1 may plex and for their ability to cleave targeted Pp-luc
require Dcr-2 to bind siRNAs. Alternatively, Dcr-1 may mRNAs. Native gel analysis revealed that the R3 com-
associate with siRNAs independently of Dcr-2 to form plex sedimented as a distinct 80S peak (Figure 5A, frac-
an R1-like complex that is normally unstable during na- tions 24–30). In addition, some of the siRNAs in these
tive gel analysis. We favor this latter possibility for two fractions were present in a band that slightly entered
reasons. First, Dcr-1 crosslinks to siRNAs in the absence the native gel (see below). Strikingly, mRNA cleavage
of Dcr-2 (Figure 4A). Second, Dcr-1 does not efficiently activity co-sedimented precisely with R3 (Figure 5B).
crosslink to siRNAs in the presence of heparin (Figure The 80S peak fractions harbor predominantly single-
4C, lane 1), which is routinely added to binding reactions stranded siRNAs, indicating that siRNPs in these frac-
before native gel electrophoresis. The decreased Dcr-1 tions have been activated for target mRNA recognition
crosslinking in the presence of heparin indicates that it and cleavage (Figure 5C). R3s sedimentation profile
likely represents a weak interaction. The Dcr-2 crosslink, naturally raises the possibility that it is a ribosome bound
on the other hand, survives the heparin challenge, sug- complex. To address this, we resolved complexes that
gesting that the Dcr-2/siRNA association is more stable were formed from total extract on a native gel and
(Figure 4C, lane 2). probed a blot of the gel for rRNAs (Supplemental Figure
S2 on the Cell website). rRNAs from both small and large
ribosome subunits comigrated with R3 complexes in theDcr-2 Transiently Associates with siRNAs Bearing
5-Hydroxyl Groups native gel, consistent with the notion that R3 physically
associates with ribosomes.While examining the presence of Dcr-2 in R1, we also
tested the biochemical requirements for Dcr-2/siRNA To determine whether these activated complexes co-
sediment with known RISC-associated factors, we ana-crosslinking. UV crosslinking experiments were per-
formed either with extracts containing ATP or those lyzed the sucrose gradient fractions by Western blot
with antibodies directed against the proteins VIG, TSN,depleted of ATP, using siRNA substrates bearing 5-
hydroxyl or 5-phosphate groups. Crosslinking reac- Ago2, and dFXR (Hammond et al., 2001; Caudy et al.,
2002, 2003; Ishizuka et al., 2002) (Figure 5D). All fourtions were then analyzed both by SDS-PAGE (Figure
4C, lanes 3–6) and native gel electrophoresis (Figure RISC-associated factors were present in the R3 peak
fractions (Figure 5D), consistent with a role for R3 as4D). The Dcr-2/siRNA crosslink did not require ATP and
surprisingly formed regardless of the 5-phosphoryla- an RNAi effector complex. Strikingly, Dcr-2 and R2D2,
components of the dsRNA processing machinery (Liu ettion status of the siRNAs (Figure 4C), although ATP did
slightly enhance the amount of crosslinked product ob- al., 2003), also co-sedimented in the same 80S fractions
(Figure 5D, left panel). Dcr-1 was present as well. Theseserved on the 5-hydroxyl siRNA (Figure 4C). In contrast,
the Dcr-1/siRNA crosslink was significantly enhanced data correlate well with our UV crosslinking results
showing that Dcr-1 and Dcr-2 are intimately associatedby ATP on both 5-hydroxyl and 5-phosphate siRNAs
(Figure 4C). When the same crosslinking reactions were with siRNAs in the R2 and R3 regions of a native gel
(Figure 4B). The immunoblot profiles were not identicalanalyzed by native gel, we observed complexes assem-
bled on 5-hydroxyl siRNA duplexes in the absence of for all proteins; for example, dFXR trails into the faster-
sedimenting fractions, consistent with its ability to asso-ATP, but only when the samples had been UV irradiated
(Figure 4D, compare lanes 4 and 8). These results indi- ciate with polysomes (Jin and Warren, 2003). Some het-
siRNP Assembly in the RNAi Pathway
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Figure 5. R3 Is an 80S Silencing Complex
that Cofractionates with mRNA Target Cleav-
age Activity and with Known RNAi Factors
(A) R3-containing Superdex-200 void frac-
tions were pooled and centrifuged on a 20%–
50% sucrose gradient. Fractions were analyzed
by native gel electrophoresis. The rightmost
lane (“Lysate”) shows siRNP complexes formed
in unfractionated extract. Sedimentation mark-
ers are indicated on the bottom; the 80S peak
was defined by rRNA detection in samples
from the same gradient fractions. The 30S,
50S, and 70S peaks were from E. coli ribo-
somes and ribosomal subunits sedimented
separately in an identical gradient. Complexes
and unbound siRNA are indicated on the right.
(B) Gradient fractions shown in (A) were used
in an mRNA target cleavage assay. Control
samples are input Pp-luc mRNA (“Input”), un-
fractionated lysate in the absence of siRNA
(“No siRNA”), and unfractionated lysate in
the presence of Pp-luc siRNA (“Complete”).
The mobilities of 5 end-labeled uncleaved
Pp-luc mRNA target and cleaved product are
shown on the right.
(C) Sucrose gradient fractions were depro-
teinized, precipitated, and loaded onto a 15%
native polyacrylamide gel as described by
Nyka¨nen et al. (2001). Annealed siRNAs (“du-
plex”) and heat-denatured siRNAs (“duplex
heat”) were used both as markers and as con-
trols to ensure that the procedure did not
result in spurious denaturation or renatu-
ration during handling. The siRNA duplex and
the unwound 3 end-labeled antisense strand
are given on the right. The asterisk denotes
the 3 end label.
(D) In the panel on the left, unfractionated
lysate (“Total”) and sucrose gradient frac-
tions from (A) were separated in SDS poly-
acrylamide gels, blotted onto nitrocellulose,
and subjected to Western analysis using anti-
bodies against VIG, Ago2, dFXR, TSN, Dcr-1,
Dcr-2, and R2D2, as indicated. The 80S sedi-
mentation marker is shown at the bottom and
was defined by rRNA detection in samples
from the same gradient fractions. The panel
on the right shows Western analysis of sucrose
gradient fractions from siRNA-free lysate.
erogeneity may exist among the 80S siRNA-con- tionally and physically, to the Dcr-2/R2D2 RNAi initiator
complex. The siRNA/Dcr-2 interaction formed in the initi-taining complexes.
When we treated naı¨ve extracts with the same chro- ator complex appears to persist in the effector, even
after siRNA unwinding.matographic and centrifugation procedures, we did not
detect Dcr-2 or R2D2 in comparable fractions (Figure If R3 is, indeed, an effector complex, then it should
be able to bind targeted mRNAs in a cognate-siRNA-5D, right panel), even though the signal intensities of the
two blots can be directly compared (see Experimental dependent manner. To test this, we used a radiolabeled,
2-O-methyl target that cannot be cleaved by RISCProcedures). VIG, TSN, Ago2, and dFXR, however, sedi-
ment in the 80S region of the gradient in the absence (Schwarz et al., 2003). The target was incubated in ex-
tracts containing either unlabeled cognate or noncog-of siRNAs, possibly due to their presence in endogenous
miRNA-programmed RISCs (Hutvagner et al., 2001). nate siRNA duplexes and analyzed by native gel electro-
phoresis. In the presence of the cognate—but not theConsistent with this possibility, low levels of Dcr-1
(which is required for the miRNA pathway; Lee et al., noncognate—siRNA duplexes, the target analog was
bound by complexes that migrated identically with R32004) were detected in fraction 30 from naı¨ve extract
(Figure 5D, right panel). Together, these results indicate (Figure 6, compare lanes 4 and 5). When this experiment
was performed with dcr-2 mutant lysate, the 2-O-that R3 may be an effector complex that is linked, func-
Cell
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360 kDa siRNP complex that contains duplex siRNAs
and is inactive for targeted mRNA cleavage (Nyka¨nen
et al., 2001). It is also probably equivalent to a dsRNA-
processing complex isolated from Drosophila S2 cells
that contains Dcr-2 and R2D2 (Liu et al., 2003). R1 shares
many features with this complex and can also form in
extracts prepared from S2 cells (data not shown). Based
on our results, as well as those of Liu et al. (2003), we
conclude that the factors that form R1 process dsRNA
and initiate RISC assembly. Furthermore, our results
indicate that siRNAs must interact with Dcr-2 in order
to reach RNAi effector complexes and that Dcr-2/siRNA
association within the R1 complex is the first detectable
step in the RISC-assembly pathway. Intriguingly, UV
crosslinking results indicate that Dcr-2 can weakly or
transiently bind 5-hydroxyl-bearing siRNAs in the R1
complex. Nyka¨nen et al. (2001) proposed that the siRNA
5-phosphate serves a “licensing” function in the RNAi
pathway, allowing the silencing machinery to recognize
bona fide siRNAs; if this is true, our results indicate that
siRNA 5-phosphorylation status is monitored within the
R1 complex after the initial Dcr-2/siRNA interaction has
occurred. This could be achieved by fast dissociation
of 5-hydroxyl siRNAs from the Dcr-2 complex.
We have not yet characterized the R2 complex in
detail because it neither survives gel filtration chroma-
tography nor sediments cleanly in a sucrose gradient
(data not shown). For now, we can only speculate about
Figure 6. R3 Complex Binds mRNA Target in a Cognate-siRNA-
its composition and role in RNAi. Based on its kineticsDependent Manner
and behavior in a chase experiment, R2 may be an inter-
(A) Radiolabeled Pp-luc 2-O-methyl mRNA analog was incubated
mediate that links R1 and R3, although we cannot bewith wild-type lysate (lanes 3–5) or dcr-2 mutant lysate (lanes 6–8)
certain that it is “on pathway.” Since R2 forms so rapidlyin the absence of siRNA (lanes 3 and 5), in the presence of unlabeled
in this experiment, it might arise from R1 binding to anoncognate Rr-luc siRNA (lanes 4 and 7), or in the presence of
unlabeled cognate Pp-luc siRNA (lanes 5 and 8). Samples were set of pre-associated factors (or to a single factor). This
then treated with heparin and loaded onto a native gel. Unbound binding may then trigger the recruitment of still more
radiolabeled Pp-luc 2-O-methyl mRNA analog is shown in lane 1. factors, possibly accompanied by conformational re-
Wild-type lysate incubated with radiolabeled Pp-luc siRNA (lane 2)
arrangements, because relative to the other complexes,serves as a marker for complexes that are indicated on the right.
R2s mobility in a native gel decreases slightly with timeIn addition, a nonspecific (i.e., Dcr-2- and siRNA-independent) com-
(Figures 3D and 3E). siRNA unwinding may occur duringplex that forms on the mRNA target is denoted with an arrow.
this process, leading to formation of R3.
The R3 complex is significantly enhanced by incuba-
tion with ATP, a known requirement for activated RISCmethyl target did not comigrate with R3 (Figure 6, lanes
formation. R3 is very large (80S) and cofractionates with6–8). Because the dcr-2 mutant extract is incapable of
the known RISC-associated components VIG, TSN, Ago2,forming the R3 complex (Figure 1), this result indicates
and dFXR. The siRNAs associated with R3 are singlethat the target binding activity is, in fact, R3. Together,
stranded, and the complex co-sediments precisely withthe data demonstrate that R3 is an RNAi effector com-
mRNA target cleavage activity. Finally, R3 can bind aplex that can bind and cleave targeted mRNAs.
cognate mRNA target. Based on these results, we con-
clude that R3 is an RNAi effector complex that is signifi-
Discussion cantly larger than those previously described.
Throughout the course of this work, we frequently
A Model for Silencing Complex Assembly observed radiolabeled RNA at the top of the native gel
and Function in RNAi lanes, which we labeled with an asterisk. This kind of
We have shown that Drosophila RNA silencing com- material is common in native gel analyses of large nu-
plexes can be resolved by native gel electrophoresis cleoprotein complexes like spliceosomes (e.g., Konar-
and have further demonstrated that these complexes ska and Sharp, 1986), ribosomes (e.g., Nadano et al.,
act at defined stages in the RNAi pathway. Our data are 2001), and transcription factor complexes (e.g., Shaw
consistent with a model in which the complexes form et al., 1989) and is typically left uncharacterized. It may
sequentially, in a pathway that begins and ends with represent a distinct functional complex, a portion of the
Dicer, ultimately leading to target mRNA destruction R1, R2, and R3 complexes that has difficulty entering
(Figure 7). the gel, a nonspecific complex, or some combination
Of these complexes, R1 forms the earliest. It does not of these possibilities. It is difficult to unambiguously
require ATP to form and contains Dcr-2, which directly characterize this material. At least some of it forms inde-
pendently of ATP and Dcr-2 (Figure 1), inconsistent withbinds siRNAs. R1 corresponds to a previously identified
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Figure 7. Models for siRNP Assembly and RNAi in Drosophila
The dsRNA or siRNA silencing trigger is shown in red. R1 complex can arise either from Dcr-2 activity on long dsRNA triggers or from
exogenous pre-cleaved siRNAs. R1 has already been shown to contain duplex siRNAs, and the ATP independence of R2 suggests that its
formation also precedes siRNA unwinding. Both R2 and R3 complexes form from R1. We cannot formally exclude the possibility that R2 is
an off-pathway dead-end complex; accordingly, two possible pathways are shown that differ in the placement of R2, either on (A) or off (B)
the productive RNAi pathway. Additional complexes may be involved (see Discussion). The siRNA is unwound in the R3 complex. Known
RNAi factors are indicated, and the presumably numerous as-yet-unidentified RNAi factors are shown as question marks. See text for references.
its role as an RNAi effector. On the other hand, at least from target messages (Olsen and Ambros, 1999), sug-
gesting further functional links between RISC and ribo-some of it co-sediments with R3 and (in the experiment
shown in Figure 5A) appears to slightly enter the gel, somes. In S2 cells, Drosophila RISC components pellet
with ribosomes and other large complexes after high-consistent with the possibility that it is a discrete silenc-
ing complex. We cannot conclusively rule out the possi- speed centrifugation (Hammond et al., 2001; Caudy et
al., 2002, 2003). Two of these components, Ago2 andbility that siRNAs present at the top of the native gel
lanes are associated with distinct functional complexes. dFXR, are found in complexes that include 5S rRNA as
well as two ribosomal proteins, L5 and L11 (Ishizuka etHowever, our analyses point to R3 as an especially com-
pelling candidate for the RNAi effector. al., 2002). siRNAs have also been found in association
with the translational machinery, interacting with polyri-Our experiments suggest that R3 is a ribosome bound
silencing complex. Indeed, several lines of evidence link bosomes in the protozoan Trypanosoma brucei (Djikeng
et al., 2003).RNAi to translation and therefore support this possibil-
ity. In Drosophila oocytes, untranslated mRNAs are re- If R3 is a ribosome bound complex, then it is likely
that RISC binds during or after siRNA unwinding andfractory to RNAi, whereas those actively undergoing
translation are not (Kennerdell et al., 2002), indicating activation. We base this assertion both on the apparent
ATP dependence of R3 formation and on the preponder-that mRNAs most susceptible to RNAi are those that
can also interact with the translational machinery. Mi- ance of single-stranded siRNAs within the complex. Za-
more and coworkers previously showed that siRNA un-croRNAs have been identified within RISC (Hutvagner
and Zamore, 2002) and can also affect protein synthesis winding requires ATP (Nyka¨nen et al., 2001). Although
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tions were performed in standard RNAi reaction conditions as pre-we cannot rule out the possibility that a potential RISC/
viously described (Tuschl et al., 1999), but with slight modifications.ribosome interaction requires ATP for unrelated rea-
GTP, CTP, UTP, and amino acids were omitted from both mRNA andsons, our data indicate that siRNA unwinding is one
dsRNA cleavage reactions; furthermore, cleavage reactions with
source of that requirement. Once formed, the R3 com- dsRNA substrates were supplemented with magnesium chloride
plex may be biochemically separable since smaller, ac- (2.5 mM final concentration).
Pp-luc mRNAs were transcribed with T7 RNA polymerase to gen-tive RISCs have been identified (Hammond et al., 2001;
erate a 465 nucleotide (nt) product. The transcripts were thenNyka¨nen et al., 2001; Martinez et al., 2002). If so, then R3
7-methylguanosine-capped using guanylyl transferase (Ambion)may represent a holo-silencing complex that includes
and [-32P]-GTP (ICN) according to the manufacturer’s instructions.factors not absolutely required for mRNA cleavage activ-
In our initial experiments, we used guanylyl transferase that was
ity in vitro. These factors may include regulatory ele- kindly provided by P. Zamore. Pp-luc dsRNAs were prepared by
ments or those involved in the miRNA silencing pathway. transcribing sense and antisense strands using T7 and SP6 RNA
polymerase, respectively. Transcription reactions were performed
in the presence of [-32P]-UTP (ICN) to give internally radiolabeledOn the Roles of Dcr-1, Dcr-2, and R2D2
products, 465 nt (sense) or 460 nt (antisense) long. The productsin RNA Silencing
were mixed, 1:1, in annealing buffer (30 mM HEPES [pH 7.5], 100
Because dsRNA processing and mRNA target cleavage mM potassium acetate, 2 mM magnesium acetate), heated at 95C
activities are biochemically separable, Dicer is generally for 2 min, and annealed overnight at 37C to give duplex RNA.
thought to release siRNAs to RISC, playing no apparent The synthetic Pp-luc siRNAs used in target mRNA cleavage, UV
crosslinking, and native gel experiments were identical to thoserole in the effector phase of RNAi. However, the pres-
described previously (Nyka¨nen et al., 2001). The antisense RNA wasence of Dcr-2 and R2D2 in R3-containing sucrose gradi-
3-end labeled with [32P]-cordycepin 5-triphosphate (New Englandent fractions raises interesting questions about their role
Nuclear) using poly (A) polymerase (Amersham) according to the
in RNA silencing, especially since they are not detect- manufacturer’s instructions. For standard target mRNA cleavage
able in the corresponding fractions collected from naı¨ve reactions, the siRNAs were used unlabeled. Duplex siRNAs were
extracts. Liu et al. (2003) have argued that the Dcr-2- prepared by annealing the single-stranded RNAs in annealing buffer
for 1 hr at 37C after a 2 min incubation at 95C.associated protein R2D2 conveys siRNAs from the RNAi
initiator complex to the effector complex. Our data in-
Native Gel Electrophoresisstead indicate that the Dcr-2/R2D2 initiator complex,
32P-labeled siRNA duplexes were incubated either in a 10l standarditself, is incorporated into the effector in a RISC assem-
RNAi reaction mixture or one depleted of ATP using hexokinasebly pathway.
and glucose, as previously described (Zamore et al., 2000). In both
Our sucrose gradient experiments indicate that RISC cases, the mixtures were supplemented with glycerol (10% v/v final
components may associate with each other even in the concentration), incubated for 30 min, and quenched with 2 l of a
absence of exogenous siRNAs. This association is not heparin mix (60 mM potassium phosphate, 3 mM magnesium chlo-
ride, 3% PEG8000, 8% glycerol, 4 mg/ml heparin), yielding a finallikely to be an apo-complex because fractionated naı¨ve
heparin concentration of 0.67 mg/ml. They were then loaded ontoextracts cannot form R3 when they are incubated with
a pre-chilled, 4% (40:1 acrylamide:bisacrylamide) native gel and runsiRNA duplexes after fractionation. Rather, it may repre-
at 4C in 1 TBE at 10W. For timecourse experiments, the zero time
sent endogenous microRNA-programmed RISC com- point was pre-quenched with heparin before extract was added.
plexes or perhaps a partially preformed “holo-RISC” that For target binding experiments (Figure 6C), we used a Pp-luc,
lacks essential assembly factors (such as Dcr-2 and 2-O-methyl target analog with the sequence 5-AUCAGUACGCG
GAAUACUUCGAdAdA-3. This target was 5-end labeled withR2D2). Since the silencing activities of RISC and the
-32P ]-ATP using T4 polynucleotide kinase (New England Biolabs).miRNP are apparently governed by the degree of com-
The labeled target analog was incubated in a standard RNAi reactionplementarity between trigger and target, and not by the
mixture (containing wild-type or dcr-2 mutant lysate) supplemented
identity of the silencing complex (Hutvagner and Za- with 10% (v/v) glycerol in the presence of an unlabeled cognate
more, 2002; Doench et al., 2003; Zeng et al., 2003), R3 (Pp-luc) or a noncognate siRNA duplex. After 1 hr, the reactions
may be able to form on both siRNAs and miRNAs. If so, were quenched with heparin, loaded onto a 4% (40:1) native poly-
acrylamide gel, and run as described above.then there may be distinct mechanisms for incorporating
For rRNA Northern blots, standard RNAi reaction mixtures weresiRNA and miRNA triggers into the silencing complex.
incubated at 25C for 30 min with or without 50 nM unlabeled siRNAssiRNA incorporation into RISC is likely to proceed on a
and then loaded and run on a 4% (40:1) native gel. RNA from the
Dcr-2/R2D2-dependent pathway since Dcr-2 and R2D2 gel was transferred to a Zeta-Probe GT membrane (Bio-Rad) and
can process dsRNAs (Liu et al., 2003) but are not detect- probed as previously described (Konarska and Sharp, 1986). The
able in sucrose gradient fractions collected from naı¨ve sequences of the oligonucleotide probes complementary to Dro-
sophila rRNAs were 5-AAGCACATGTCCCATAAGGTTCATG-3extracts. On the other hand, miRNA incorporation may
(18S) and 5-GCTTAATTTCGGTGATCGGACGAGA-3 (5S).proceed on a different pathway to the silencing complex,
possibly relying on Dcr-1. There is support for this model
Chromatographyin the apparent division of labor between Dcr-1 and
Gel filtration chromatography was performed as previously de-Dcr-2 in processing miRNA and dsRNA triggers (Lee et
scribed (Nyka¨nen et al., 2001), with slight modification. Samples
al., 2004). If this model is correct, then the observed were chromatographed at 4C with a flow rate of 0.45 ml/min on an
size of R3 may reflect the diverse roles it may play, from A¨KTA FPLC system. For anion exchange chromatography, naı¨ve
mRNA cleavage to translational control. extracts were chromatographed first by gel filtration as described
above. Aliquots of the fractions were incubated with 32P-labeled
siRNAs for 30 min at 25C in a standard RNAi reaction containingExperimental Procedures
glycerol (10% v/v total). Reactions were then treated with heparin
(see above) and assayed for complex formation on a 4% (40:1) nativeGeneral Methods
Drosophila embryo lysates were prepared from Canton S or polyacrylamide gel at 4C. The remainder of the R1-forming fractions
were pooled, supplemented with carrier insulin (final concentrationdcr-2L811fsX mutant flies (Lee et al., 2004) as previously described
(Tuschl et al., 1999). Similarly, the mRNA and dsRNA cleavage reac- 0.25 mg/ml) (Sigma), concentrated (Microcon YM-30, Millipore), and
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loaded onto a 1 ml HiTrap Q column (Amersham). The unbound The samples were precipitated with ethanol, resuspended (10 l,
3% w/v Ficoll-400, 0.04% Bromophenol Blue, and 2 mM Tris-HClsample was washed with 5 column volumes of buffer (50 mM NaCl
in 20 mM Tris-Cl [pH 7.9]). The sample was then eluted in a two- [pH 7.4]), and run on a 15% native polyacrylamide gel at 4C as
previously described (Nyka¨nen et al., 2001).step gradient. In the first step, the salt concentration was increased
linearly from 50 mM to 500 mM in 1 column volume. In the second For Western analysis on both naı¨ve and siRNA-programmed ex-
tracts (Figure 5D), 20 l of each even-numbered fraction betweenstep, it was increased linearly to 1 M in 8 column volumes. Five
hundred microliter fractions were collected during these two steps. 18 and 36 was loaded and run on SDS-polyacrylamide gels. Identical
amounts of unfractionated extract were loaded into the “total” laneThe fractions were supplemented with carrier insulin (as before),
desalted, and concentrated (Microcon YM-30) to 65 l. These frac- of gels from both naı¨ve and siRNA-programmed extracts to allow
for direct comparison of signal intensities. The proteins were trans-tions were used at 1 for native gel analysis (as described above)
and diluted 1:10 in annealing buffer (see above) for the dsRNA pro- ferred to nitrocellulose membranes (Protran, Schleicher & Schuell),
probed with primary, then secondary antibody (HRP-conjugatedcessing assay. Fractions were also diluted (1:10) in dcr-2 mutant
extract and assayed for target mRNA cleavage and native gel com- goat anti-rabbit, Pierce), incubated in a peroxide/enhancer solution
(SuperSignal West Femto, Pierce), and visualized by autoradiogra-plex formation.
phy. Ago-2 antibodies were provided by E. Izaurralde; Dcr-2 and
R2D2 antibodies were provided by Q. Liu and X. Wang; and the VIG,UV Crosslinking
TSN, dFXR, and Dcr-1 antibodies were provided by A. Caudy and32P-labeled siRNA duplexes were incubated for 30 min at 25C in
G. Hannon.either a 10 l standard RNAi reaction mixture or one depleted of
ATP. The reactions were placed onto a parafilm-covered, pre-
Acknowledgmentschilled, metal block in ice and exposed to 254 nm light (at full power)
for 30 min in a Stratalinker 2400 (Stratagene). The reactions were
We are very grateful to P. Zamore for the guanylyl transferase thatthen analyzed by SDS-PAGE or supplemented with glycerol (10%
we used in our early experiments; A. Caudy, G. Hannon, and E.final concentration), quenched with 2 l of heparin mix (see above),
Izaurralde for antibodies; and Q. Liu and X. Wang for antibodiesand analyzed by native gel electrophoresis.
and for communicating results before publication. We thank J. GorraFor the two-dimensional analysis, a 10l standard RNAi reaction
and Z. He for help with fly maintenance and lysate preparation, R.was crosslinked and subjected to native gel electrophoresis as de-
Lieberman for assistance with column chromatography, T. Karginovscribed above. The entire gel lane was then excised, embedded
and R. Fahlman for help with sedimentation analysis, and P. Bellare,orthogonally in the stacking portion of an 8% SDS-polyacrylamide
A. Lamond, J. Staley, and O. Uhlenbeck for comments on the manu-gel, and run in a second dimension.
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